Vivos Therapeutics Inc. (VVOS)

3.26

-0.21 (-6.05%)

At close: Mar 03, 2025, 3:59 PM

3.17

-2.76%

After-hours: Mar 03, 2025, 06:12 PM EST

Vivos Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-13.58M	-23.84M	-20.29M	-12.06M	-10.75M	-8.44M
Depreciation & Amortization	621K	669K	733K	717.87K	751.23K	610.67K
Stock-Based Compensation	n/a	2.4M	2.66M	2.17M	1.99M	1.28M
Other Working Capital	1.88M	474K	-507K	70.15K	1.86M	1.15M
Other Non-Cash Items	-1.85M	-518K	-9K	3.92M	83.07K	364.34K
Deferred Income Tax	n/a	n/a	1.14M	n/a	60.34K	n/a
Change in Working Capital	2.86M	1.71M	28K	-431.07K	2.53M	867.1K
Operating Cash Flow	-11.95M	-19.59M	-15.73M	-5.68M	-5.34M	-5.31M
Capital Expenditures	-803K	-924K	-2.4M	-120.25K	-175.6K	-1.25M
Acquisitions	n/a	n/a	-225K	n/a	250K	133.34K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-924K	13K	-120.25K	11.82K	n/a
Investing Cash Flow	-853K	-924K	-2.61M	-120.25K	86.22K	-1.12M
Debt Repayment	n/a	n/a	-25K	1.19M	3.73M	-88.24K
Common Stock Repurchased	n/a	n/a	-1.5M	-2.15M	-350K	-1M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.08M	n/a	-3.74M	56.86K	388.61K	-1.01M
Financial Cash Flow	10.92M	n/a	24.17M	23.54M	4.47M	5.25M
Net Cash Flow	-1.88M	-20.51M	5.82M	17.74M	-785.37K	-1.18M
Free Cash Flow	-12.75M	-20.51M	-18.13M	-5.8M	-5.52M	-6.56M